Methods for the treatment of hematological malignancies

Abstract

Described herein are methods of treating a hematological malignancy, including minimal residual disease in hematological malignancies, and methods of preventing relapse of hematological malignancies, the methods comprising administering an inflammasome modulator. In some embodiments the method of treatment comprises administering a compound of formula (I): or a pharmaceutically acceptable salt or solvate thereof, wherein the variables are as defined herein.